Corologic Secures Seed Funding with Support from Seoul National University Technology Holdings and Kakao Ventures

Corologic Raises Seed Funding

Corologic, a Seoul-based company specializing in real-time generative reconstruction for lower-dose coronary angiography, has raised an undisclosed amount in a seed funding round. The investment was backed by Seoul National University Technology Holdings and Kakao Ventures.

Company Vision and Leadership

Corologic aims to enhance clinical imaging workflows by developing advanced technology for coronary angiography. The company is led by a team of co-founders: Kang Si-hyeok, who serves as the Chief Marketing Officer, KyungRae Hwang, the Chief Executive Officer, and Youngrak Choi, the Chief Technology Officer.

Investors and Strategic Goals

The seed round was supported by prominent investors including Seoul National University Technology Holdings and Kakao Ventures. Although specific plans for the use of funds were not disclosed, the backing from these investors is expected to bolster Corologic's technological advancements and market reach.

Future Prospects

With the new capital, Corologic is poised to enhance its offerings in the healthcare sector by focusing on its innovative imaging solutions. The company is expected to continue developing its technology to meet the growing demand for efficient and accurate medical imaging.

For more information about Corologic, visit their website.